(2S,3R)-3-amino-4-phenyl-1-(3-phenylpiperidin-1-yl)butan-2-ol;methane;sulfane;dihydrochloride
C22H36Cl2N2OS — CID 158132619
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S,3R)-3-amino-4-phenyl-1-(3-phenylpiperidin-1-yl)butan-2-ol;methane;sulfane;dihydrochloride
(2S,3R)-3-amino-4-phenyl-1-(3-phenylpiperidin-1-yl)butan-2-ol;methane;sulfane;dihydrochloride (PubChem CID 158132619) has the molecular formula C22H36Cl2N2OS and a molecular weight of 447.52 g/mol. Its IUPAC name is (2S,3R)-3-amino-4-phenyl-1-(3-phenylpiperidin-1-yl)butan-2-ol;methane;sulfane;dihydrochloride.
Molecular Properties
| Compound Name | (2S,3R)-3-amino-4-phenyl-1-(3-phenylpiperidin-1-yl)butan-2-ol;methane;sulfane;dihydrochloride |
|---|---|
| PubChem CID | 158132619 |
| Molecular Formula | C22H36Cl2N2OS |
| Molecular Weight | 447.52 g/mol |
| Exact Mass | 446.19 |
| IUPAC Name | (2S,3R)-3-amino-4-phenyl-1-(3-phenylpiperidin-1-yl)butan-2-ol;methane;sulfane;dihydrochloride |
| SMILES | C.Cl.Cl.N[C@H](Cc1ccccc1)[C@@H](O)CN1CCCC(c2ccccc2)C1.S |
| InChI | InChI=1S/C21H28N2O.CH4.2ClH.H2S/c22-20(14-17-8-3-1-4-9-17)21(24)16-23-13-7-12-19(15-23)18-10-5-2-6-11-18;;;;/h1-6,8-11,19-21,24H,7,12-16,22H2;1H4;2*1H;1H2/t19?,20-,21+;;;;/m1..../s1 |
| InChIKey | WFTCQINMGRTRRV-WCSOPIHJSA-N |
| XLogP | 4.39 |
| TPSA | 49.49 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 447.52 |
| LogP ≤ 5 | 4.39 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158132619 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.